CU Healthcare Innovation Fund

The fund is directly linked to the University of Colorado's medical enterprise and operates to commercialize research originating from CU faculty and clinical programs. It targets spin-offs and start-ups built around university-developed intellectual property. This captive relationship provides a sourcing channel distinct from independent venture firms in the digital health and healthcare services space.

The strategy concentrates on the earliest phases of company formation — specifically seed and start-up rounds. The fund also engages in spin-offs, meaning it may form new companies around specific university technologies rather than only investing in existing startups. Its venture generalism is applied within a healthcare-only mandate.

The available record identifies the fund's strategy as co-investment and direct venture, with no mention of fund-of-fund commitments. The co-investment designation indicates the fund writes checks alongside other institutional or venture partners into specific companies, rather than serving as a limited partner in blind-pool funds.

The fund's mandate is explicitly confined to healthcare, structured around digital health and healthcare services. It does not invest in non-healthcare technology, consumer goods, or financial services. Its deal flow is tied to academic medical commercialization, making it unlikely to stray outside regulated healthcare and adjacent health technology verticals.

No. CU Healthcare Innovation Fund has not publicly released AUM figures or aggregate deployment numbers. Without a formal disclosure from the firm or a named external publication, the scale of capital it manages remains undisclosed.